Real-world effectiveness and safety of adebrelimab as first-line treatment in patients with extensive-stage small cell lung cancer. [PDF]
Lv T +18 more
europepmc +1 more source
Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola +11 more
wiley +1 more source
Real-Time Assistive System Integrating Geometric Topology Analysis and State-Adaptive Warning Logic for the Visually Impaired. [PDF]
Hu B, Gao P, Liu Y, Xia X, Huo G.
europepmc +1 more source
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim +3 more
wiley +1 more source
Methodological clarifications on maintenance fluoropyrimidines in advanced esophagogastric adenocarcinoma: a real-world Mexican cohort. [PDF]
Dip Borunda AK +6 more
europepmc +1 more source
A comparative study of vision-language models for food ingredient recognition and nutrient estimation. [PDF]
Wang S, Sheng G, Yan H, Min W, Jiang S.
europepmc +1 more source
Duration of systemic therapy in patients with metastatic <i>EGFR</i>-mutated non-small cell lung cancer and brain metastases. [PDF]
Yan M +6 more
europepmc +1 more source
Biweekly carboplatin plus nab-paclitaxel with concurrent radiotherapy followed by durvalumab consolidation for unresectable locally advanced non-small cell lung cancer: a real-world retrospective cohort study. [PDF]
Nunomura Y +14 more
europepmc +1 more source
Utidelone exhibits favorable responses in refractory patients with advanced breast cancer. [PDF]
Bai X +10 more
europepmc +1 more source

